Moneysoft reportedly secures an additional AU$500,000 in a new round of funding, bringing its total funding to AU$1.5 million. The application offers a free budget planner and money management software that allows its users to categorize and track...
Deals
Cancer research startup Juno Therapeutics raises $300 million in less than a year
Seattle-based Juno Therapeutics announced it has closed Series B round of funding with $134 million. The new funding came from previous investors including ARCH Venture Partners, Alaska Permanent Fund, Bezos Expedition, the personal investment company of Amazon founder Jeff Bezos, and Venrock. Also participating in Series B are 10 other mutual funds and healthcare-related funds that wish to remain anonymous.
Vectra Networks gets a total of $42.8 million after recent Series C funding
Vectra Networks managed to raise additional $25 million in its Series C funding from existing investor Accel Partners and other investors, including AME Cloud Ventures, IA Ventures and Khosla Ventures participating in the round, Intel Capital and Juniper Networks, through its Junos Innovation Fund. The new investment will be used to boost sales, marketing efforts as well as engineering.
Metanautix gets $7 million in initial funding
Metanautix has received $7 million in initial funding from Sequioa Capital, the Stanford University Endowment Fund and Shiva Shivakumar, a former VP of engineering at Google. The company plans to release its first product for general availability before the end of 2014. At present, there are half a dozen beta customers using the software, with the largest being Hewlett-Packard.
Spoqa raises $3.9 million in Series B, looks to Japan for expansion
Seoul-based Spoqa has raised $3.9 million in Series B funding from Daesung Private Equity Group and Bokwang Investments, and plans to use the investment for expansion in Japan.
Latest News
As part of its expansion plans in Japan and mainland China, Hong Kong-based 8 Securities managed to raise $9 million in a Series B funding round. Velocity Capital and Leitmotiv Private Equity returned as its investors.
DragonWave Inc announced it was closing an underwritten public offering of units including full exercise of the over-allotment option. The net proceeds are estimated at CA$ 26.9 million. The company said it plans to use the net proceeds from the offering to strengthen its balance sheet, to fund working capital and for general corporate uses.
Israeli-company EndyMed Ltd has reached an agreement with the Chinese OHMK Medical Technology, which will acquire 47.93 million EndyMed shares (28.94 percent share capital and voting rights), for $7 million.
Enumeral Biomedical Holdings announced that it had completed a merger between the company and its subsidiary, Cerulean Group, Inc. Along with the news of the merger, the company also announced the conclusion of its private placement financing, which raised $21.5 million.
The California Energy Commission recently endowed a $3 million grant to Pacific Ethanol to develop a product that would act as an alternative for sorghum. Sorghum is being used as a feedstock for ethanol.
Destiny Pharma recently announced in a press release that it was able to raise £2.8 million to fund the clinical trial of a drug aimed to prevent post-surgical infections. The company's recent funding, which was led by British government-backed Angel CoFund, will aid
OneRoofEnergy has made an announcement about funding it has received from an existing shareholder. The company, which is known for its SolarSelect program, acknowledged receipt...
Hallspot, a social network and mobile application aimed at establishing connections between college students and businesses, recently reached a million dollars in its third round of funding, according to the company.
P2i, a technology spin-off from Britain's Ministry of Defence, is looking to raise as much as 10 million pounds ($17 million) from Singapore investors as it readies the launch of its "Dunkable" or waterproof technology for smartphones and tablets.
